NCT01530477

Brief Summary

This study is being conducted to examine the performance of three common DXA machines (1) Lunar iDXA, (2) Lunar Prodigy and (3) Hologic Discovery A in measuring bone density and body fat.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 6, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 10, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

September 25, 2014

Completed
Last Updated

September 16, 2016

Status Verified

August 1, 2016

Enrollment Period

11 months

First QC Date

February 6, 2012

Results QC Date

June 26, 2013

Last Update Submit

August 8, 2016

Conditions

Keywords

Bone mineral densityweightbody compositionDEXADXA

Outcome Measures

Primary Outcomes (1)

  • Short Term Precision Comparison Across Three DXA Devices

    BMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the "Skeletal \& Body Composition" cohort identified in participant flow and overall study summary will not have an analysis provided.

    Less than 6 months

Study Arms (3)

Skeletal

EXPERIMENTAL

Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of three systems \[Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)\], and 60 will be measured on all three systems \[Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)\],(total of evaluable 90 subjects). \*\* Subjects can enroll in both Skeletal and Body Composition cohorts. Analysis will be performed within each cohort.\*\*

Device: Lunar Prodigy (GEHC)Device: Lunar iDXA (GEHC)Device: Discovery A (Hologic

Body Composition

EXPERIMENTAL

Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems \[Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)\], and 60 will be measured on all three systems \[Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)\], (total of evaluable 90 subjects). \*\* Subjects can enroll in both Skeletal and Body Composition cohorts. Analysis will be performed within each cohort.\*\*

Device: Lunar Prodigy (GEHC)Device: Lunar iDXA (GEHC)Device: Discovery A (Hologic

Skeletal & Body Composition

EXPERIMENTAL

"Skeletal and Body Composition" was not a cohort that was actively recruited to, it is a cohort for reporting purposes. Subjects will be measured on two of three systems \[Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)\]Subjects were able to consent and enroll to both Skeletal and Body Composition cohorts and these subjects will be counted for under this joint cohort.

Device: Lunar Prodigy (GEHC)Device: Lunar iDXA (GEHC)Device: Discovery A (Hologic

Interventions

Lunar Prodigy (GEHC) used to obtain Skeletal, and/or Body Composition measurements

Body CompositionSkeletalSkeletal & Body Composition

Lunar iDXA (GEHC) used to obtain Skeletal, and/or Body Composition measurements

Body CompositionSkeletalSkeletal & Body Composition

Discovery A (Hologic) used to obtain Skeletal, and/or Body Composition measurements

Body CompositionSkeletalSkeletal & Body Composition

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women \> 20 years old
  • Willing to provide consent
  • Falls into one of three weight categories, with minimum 30 subjects per category.
  • Less than 200 lbs.
  • (inclusive) to less than 350 lbs.
  • (inclusive) to less than 450 lbs.
  • Participate in only one weight category in either skeletal or body composition cohort, or both.

You may not qualify if:

  • Inability to remain still for the duration of the DXA scans as judged by study Investigator.
  • Un-removable internal / external scan artifacts e.g. plaster casts, metal rodding naso-gastric tubes, etc.
  • Females of childbearing potential\* with actual (confirmed by positive urine pregnancy test) or suspected (based on study Investigator evaluation despite a negative urine test) pregnancy.
  • Subject had already given consent to participate in any aspect of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Colorado Center for Bone Research

Lakewood, Colorado, 80337, United States

Location

MeSH Terms

Conditions

Bone Diseases, MetabolicBody Weight

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Yi Xia
Organization
GE Healthcare

Study Officials

  • Paul Miller, MD

    Study site

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2012

First Posted

February 10, 2012

Study Start

January 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

September 16, 2016

Results First Posted

September 25, 2014

Record last verified: 2016-08

Locations